| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.832 | 0.003 | 0.832 | 5 Hydroxytryptamine release stimulant | 0.716 0.006 CHEMBL3544658 0.731 0.005 CHEMBL2074678 0.731 0.005 CHEMBL3544659 0.778 0.004 CHEMBL3544674 0.279 0.077 CHEMBL3526778 0.652 0.01 CHEMBL3526716 | ||
| 0.588 | 0.005 | 0.588 | 5 Hydroxytryptamine 2 antagonist | 0.268 0.019 CHEMBL3544658 0.279 0.018 CHEMBL2074678 0.279 0.018 CHEMBL3544659 0.297 0.016 CHEMBL3544674 0.089 0.081 CHEMBL3526778 | ||
| 0.574 | 0.004 | 0.644 | 5 Hydroxytryptamine uptake inhibitor | 0.519 0.004 CHEMBL3544658 0.445 0.004 CHEMBL2074678 0.445 0.004 CHEMBL3544659 0.644 0.004 CHEMBL3544674 0.221 0.01 CHEMBL3526778 0.135 0.018 CHEMBL3526716 | CHEMBL3544674 | |
| 0.539 | 0.01 | 0.539 | Anticonvulsant | 0.345 0.03 CHEMBL3544658 0.203 0.08 CHEMBL2074678 0.203 0.08 CHEMBL3544659 0.449 0.016 CHEMBL3544674 | ||
| 0.511 | 0.005 | 0.511 | 5 Hydroxytryptamine 2A antagonist | 0.168 0.024 CHEMBL3544658 0.174 0.023 CHEMBL2074678 0.174 0.023 CHEMBL3544659 0.231 0.016 CHEMBL3544674 | ||
| 0.518 | 0.034 | 0.647 | Antiobesity | 0.611 0.019 CHEMBL3544658 0.492 0.039 CHEMBL2074678 0.492 0.039 CHEMBL3544659 0.647 0.015 CHEMBL3544674 0.606 0.02 CHEMBL3526778 0.477 0.043 CHEMBL3526716 | CHEMBL3544674 | |
| 0.441 | 0.003 | 0.519 | Dopamine uptake inhibitor | 0.366 0.004 CHEMBL3544658 0.283 0.004 CHEMBL2074678 0.283 0.004 CHEMBL3544659 0.519 0.003 CHEMBL3544674 0.051 0.048 CHEMBL3526778 | CHEMBL3544674 | |
| 0.489 | 0.064 | 0.489 | Caspase 9 stimulant | 0.397 0.113 CHEMBL3544658 0.471 0.072 CHEMBL2074678 0.471 0.072 CHEMBL3544659 0.291 0.203 CHEMBL3544674 0.426 0.096 CHEMBL3526716 | ||
| 0.405 | 0.027 | 0.487 | HERG channel blocker | 0.333 0.041 CHEMBL3544658 0.242 0.069 CHEMBL2074678 0.242 0.069 CHEMBL3544659 0.487 0.017 CHEMBL3544674 | CHEMBL3544674 | |
| 0.385 | 0.012 | 0.385 | 5 Hydroxytryptamine antagonist | 0.134 0.057 CHEMBL3544658 0.139 0.054 CHEMBL2074678 0.139 0.054 CHEMBL3544659 0.165 0.043 CHEMBL3544674 | ||
| 0.366 | 0.004 | 0.481 | Adrenaline uptake inhibitor | 0.356 0.004 CHEMBL3544658 0.29 0.004 CHEMBL2074678 0.29 0.004 CHEMBL3544659 0.481 0.003 CHEMBL3544674 0.159 0.009 CHEMBL3526778 0.139 0.011 CHEMBL3526716 | CHEMBL3544674 | |
| 0.336 | 0.011 | 0.336 | Acetylcholine antagonist | 0.278 0.016 CHEMBL3544658 0.219 0.026 CHEMBL2074678 0.219 0.026 CHEMBL3544659 0.284 0.015 CHEMBL3544674 | ||
| 0.356 | 0.035 | 0.429 | Potassium channel (Voltage-sensitive) blocker | 0.301 0.049 CHEMBL3544658 0.231 0.077 CHEMBL2074678 0.231 0.077 CHEMBL3544659 0.429 0.023 CHEMBL3544674 | CHEMBL3544674 | |
| 0.332 | 0.012 | 0.332 | Cholinergic antagonist | 0.279 0.017 CHEMBL3544658 0.219 0.027 CHEMBL2074678 0.219 0.027 CHEMBL3544659 0.286 0.016 CHEMBL3544674 | ||
| 0.299 | 0.019 | 0.299 | Cholinergic | 0.22 0.038 CHEMBL3544658 0.232 0.034 CHEMBL2074678 0.232 0.034 CHEMBL3544659 0.185 0.054 CHEMBL3544674 | ||
| 0.288 | 0.016 | 0.346 | Antipruritic | 0.346 0.009 CHEMBL3544658 0.284 0.017 CHEMBL2074678 0.284 0.017 CHEMBL3544659 0.339 0.01 CHEMBL3544674 0.137 0.111 CHEMBL3526778 0.178 0.067 CHEMBL3526716 | CHEMBL3544658 | |
| 0.279 | 0.009 | 0.279 | Alpha 2 adrenoreceptor antagonist | 0.129 0.034 CHEMBL3544658 0.164 0.024 CHEMBL2074678 0.164 0.024 CHEMBL3544659 0.143 0.029 CHEMBL3544674 | ||
| 0.308 | 0.041 | 0.564 | 5 Hydroxytryptamine uptake stimulant | 0.464 0.006 CHEMBL3544658 0.454 0.007 CHEMBL2074678 0.454 0.007 CHEMBL3544659 0.564 0.003 CHEMBL3544674 0.194 0.165 CHEMBL3526778 | CHEMBL3544674 | |
| 0.281 | 0.017 | 0.281 | Alpha adrenoreceptor antagonist | 0.127 0.045 CHEMBL3544658 0.196 0.028 CHEMBL2074678 0.196 0.028 CHEMBL3544659 0.126 0.045 CHEMBL3544674 | ||
| 0.271 | 0.013 | 0.271 | Calcium channel blocker | 0.178 0.04 CHEMBL3544658 0.188 0.035 CHEMBL2074678 0.188 0.035 CHEMBL3544659 0.167 0.046 CHEMBL3544674 | ||
| 0.261 | 0.004 | 0.278 | Myeloperoxidase inhibitor | 0.278 0.004 CHEMBL3544658 0.278 0.004 CHEMBL2074678 0.278 0.004 CHEMBL3544659 0.172 0.008 CHEMBL3544674 | CHEMBL3544659 | |
| 0.258 | 0.01 | 0.363 | 5 Hydroxytryptamine agonist | 0.203 0.014 CHEMBL3544658 0.163 0.019 CHEMBL2074678 0.163 0.019 CHEMBL3544659 0.363 0.006 CHEMBL3544674 | CHEMBL3544674 | |
| 0.264 | 0.017 | 0.264 | 5 Hydroxytryptamine 2B antagonist | 0.218 0.023 CHEMBL3544658 0.254 0.018 CHEMBL2074678 0.254 0.018 CHEMBL3544659 0.216 0.024 CHEMBL3544674 | ||
| 0.241 | 0.004 | 0.351 | 5 Hydroxytryptamine 2A agonist | 0.247 0.004 CHEMBL3544658 0.261 0.003 CHEMBL2074678 0.261 0.003 CHEMBL3544659 0.351 0.003 CHEMBL3544674 0.069 0.038 CHEMBL3526778 | CHEMBL3544674 | |
| 0.257 | 0.023 | 0.301 | Acetylcholine M1 receptor antagonist | 0.23 0.031 CHEMBL3544658 0.179 0.052 CHEMBL2074678 0.179 0.052 CHEMBL3544659 0.301 0.014 CHEMBL3544674 | CHEMBL3544674 | |
| 0.237 | 0.004 | 0.402 | 5 Hydroxytryptamine 2C agonist | 0.266 0.004 CHEMBL3544658 0.211 0.004 CHEMBL2074678 0.211 0.004 CHEMBL3544659 0.402 0.003 CHEMBL3544674 0.119 0.005 CHEMBL3526778 0.07 0.015 CHEMBL3526716 | CHEMBL3544674 | |
| 0.243 | 0.015 | 0.243 | Acetylcholine muscarinic antagonist | 0.203 0.024 CHEMBL3544658 0.159 0.039 CHEMBL2074678 0.159 0.039 CHEMBL3544659 0.217 0.02 CHEMBL3544674 | ||
| 0.243 | 0.019 | 0.243 | 5 Hydroxytryptamine 3E antagonist | 0.172 0.13 CHEMBL3544674 | ||
| 0.227 | 0.004 | 0.302 | 5 Hydroxytryptamine 2 agonist | 0.236 0.004 CHEMBL3544658 0.216 0.004 CHEMBL2074678 0.216 0.004 CHEMBL3544659 0.302 0.003 CHEMBL3544674 0.051 0.037 CHEMBL3526778 | CHEMBL3544674 | |
| 0.225 | 0.004 | 0.327 | Dopamine transporter inhibitor | 0.234 0.004 CHEMBL3544658 0.197 0.004 CHEMBL2074678 0.197 0.004 CHEMBL3544659 0.327 0.003 CHEMBL3544674 0.122 0.008 CHEMBL3526778 0.102 0.011 CHEMBL3526716 | CHEMBL3544674 | |
| 0.233 | 0.016 | 0.233 | Dopamine antagonist | 0.113 0.034 CHEMBL3544658 0.128 0.03 CHEMBL2074678 0.128 0.03 CHEMBL3544659 | ||
| 0.235 | 0.019 | 0.235 | Sodium channel (voltage-gated) blocker | 0.195 0.032 CHEMBL3544658 0.174 0.04 CHEMBL2074678 0.174 0.04 CHEMBL3544659 0.175 0.04 CHEMBL3544674 0.117 0.088 CHEMBL3526778 | ||
| 0.293 | 0.078 | 0.485 | Nootropic | 0.37 0.047 CHEMBL3544658 0.313 0.069 CHEMBL2074678 0.313 0.069 CHEMBL3544659 0.485 0.022 CHEMBL3544674 0.212 0.143 CHEMBL3526778 | CHEMBL3544674 | |
| 0.267 | 0.056 | 0.267 | 5 Hydroxytryptamine 1E antagonist | 0.237 0.089 CHEMBL3544658 0.238 0.088 CHEMBL2074678 0.238 0.088 CHEMBL3544659 0.232 0.094 CHEMBL3544674 | ||
| 0.217 | 0.015 | 0.217 | Dopamine D2 antagonist | 0.095 0.034 CHEMBL3544658 0.111 0.029 CHEMBL2074678 0.111 0.029 CHEMBL3544659 | ||
| 0.213 | 0.012 | 0.213 | Alpha 2a adrenoreceptor antagonist | 0.16 0.02 CHEMBL3544658 0.196 0.014 CHEMBL2074678 0.196 0.014 CHEMBL3544659 0.126 0.028 CHEMBL3544674 | ||
| 0.204 | 0.006 | 0.204 | Acetylcholine M4 receptor antagonist | 0.094 0.034 CHEMBL3544658 0.08 0.046 CHEMBL2074678 0.08 0.046 CHEMBL3544659 0.144 0.011 CHEMBL3544674 | ||
| 0.279 | 0.09 | 0.279 | Caspase 3 stimulant | 0.222 0.14 CHEMBL2074678 0.222 0.14 CHEMBL3544659 0.245 0.117 CHEMBL3526716 | ||
| 0.193 | 0.015 | 0.193 | 5 Hydroxytryptamine 1A antagonist | 0.067 0.047 CHEMBL3544658 0.084 0.038 CHEMBL2074678 0.084 0.038 CHEMBL3544659 0.074 0.043 CHEMBL3544674 | ||
| 0.186 | 0.01 | 0.186 | Inducible nitric-oxide synthase inhibitor | 0.088 0.05 CHEMBL3544658 0.078 0.066 CHEMBL2074678 0.078 0.066 CHEMBL3544659 0.081 0.061 CHEMBL3544674 | ||
| 0.177 | 0.003 | 0.19 | 5 Hydroxytryptamine 2B agonist | 0.187 0.003 CHEMBL3544658 0.178 0.003 CHEMBL2074678 0.178 0.003 CHEMBL3544659 0.19 0.003 CHEMBL3544674 0.058 0.009 CHEMBL3526778 | CHEMBL3544674 | |
| 0.178 | 0.005 | 0.185 | Nicotinic alpha4beta2 receptor antagonist | 0.164 0.006 CHEMBL3544658 0.136 0.011 CHEMBL2074678 0.136 0.011 CHEMBL3544659 0.185 0.005 CHEMBL3544674 | CHEMBL3544674 | |
| 0.182 | 0.01 | 0.182 | Acetylcholine nicotinic agonist | 0.165 0.013 CHEMBL3544658 0.113 0.029 CHEMBL2074678 0.113 0.029 CHEMBL3544659 0.178 0.01 CHEMBL3544674 | ||
| 0.192 | 0.022 | 0.192 | Alpha 1 adrenoreceptor antagonist | 0.093 0.046 CHEMBL3544658 0.159 0.028 CHEMBL2074678 0.159 0.028 CHEMBL3544659 0.089 0.048 CHEMBL3544674 | ||
| 0.183 | 0.018 | 0.183 | 5 Hydroxytryptamine 1 antagonist | 0.067 0.056 CHEMBL3544658 0.08 0.047 CHEMBL2074678 0.08 0.047 CHEMBL3544659 0.087 0.043 CHEMBL3544674 | ||
| 0.172 | 0.012 | 0.172 | CDC-like kinase 3 inhibitor | |||
| 0.186 | 0.027 | 0.186 | Alpha 2b adrenoreceptor antagonist | 0.095 0.08 CHEMBL3544658 0.121 0.058 CHEMBL2074678 0.121 0.058 CHEMBL3544659 | ||
| 0.177 | 0.019 | 0.23 | Acetylcholine agonist | 0.169 0.021 CHEMBL3544658 0.112 0.04 CHEMBL2074678 0.112 0.04 CHEMBL3544659 0.23 0.01 CHEMBL3544674 | CHEMBL3544674 | |
| 0.193 | 0.035 | 0.193 | Sodium channel blocker | 0.165 0.048 CHEMBL3544658 0.148 0.059 CHEMBL2074678 0.148 0.059 CHEMBL3544659 0.132 0.072 CHEMBL3544674 | ||
| 0.163 | 0.006 | 0.167 | Acetylcholine M5 receptor antagonist | 0.121 0.012 CHEMBL3544658 0.084 0.023 CHEMBL2074678 0.084 0.023 CHEMBL3544659 0.167 0.006 CHEMBL3544674 | CHEMBL3544674 | |
| 0.191 | 0.041 | 0.191 | CDC-like kinase 1 inhibitor | |||
| 0.171 | 0.02 | 0.171 | Alpha 1a adrenoreceptor antagonist | 0.082 0.044 CHEMBL3544658 0.124 0.028 CHEMBL2074678 0.124 0.028 CHEMBL3544659 0.089 0.041 CHEMBL3544674 | ||
| 0.219 | 0.07 | 0.219 | Psychostimulant | 0.141 0.125 CHEMBL3544658 0.189 0.086 CHEMBL3544674 | ||
| 0.152 | 0.006 | 0.152 | Melanin-concentrating hormone receptor 1 antagonist | |||
| 0.187 | 0.045 | 0.187 | MAO inhibitor | 0.122 0.073 CHEMBL3544658 0.113 0.079 CHEMBL2074678 0.113 0.079 CHEMBL3544659 | ||
| 0.162 | 0.027 | 0.162 | Alpha 2c adrenoreceptor antagonist | 0.104 0.063 CHEMBL2074678 0.104 0.063 CHEMBL3544659 0.085 0.081 CHEMBL3544674 | ||
| 0.143 | 0.011 | 0.143 | Calcium channel L-type blocker | 0.091 0.03 CHEMBL3544658 0.102 0.023 CHEMBL2074678 0.102 0.023 CHEMBL3544659 0.103 0.023 CHEMBL3544674 | ||
| 0.146 | 0.015 | 0.146 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | |||
| 0.141 | 0.012 | 0.141 | Acetylcholine M3 receptor antagonist | 0.131 0.013 CHEMBL3544658 0.087 0.023 CHEMBL2074678 0.087 0.023 CHEMBL3544659 0.107 0.016 CHEMBL3544674 | ||
| 0.2 | 0.076 | 0.216 | Neurotrophic factor enhancer | 0.189 0.088 CHEMBL3544658 0.172 0.108 CHEMBL2074678 0.172 0.108 CHEMBL3544659 0.216 0.062 CHEMBL3544674 0.182 0.096 CHEMBL3526716 | CHEMBL3544674 | |
| 0.253 | 0.132 | 0.399 | Vasodilator, coronary | 0.198 0.184 CHEMBL3544658 0.251 0.133 CHEMBL2074678 0.251 0.133 CHEMBL3544659 0.399 0.035 CHEMBL3526716 | CHEMBL3526716 | |
| 0.125 | 0.004 | 0.13 | Purinergic P2X4 antagonist | 0.13 0.004 CHEMBL3544658 0.066 0.011 CHEMBL2074678 0.066 0.011 CHEMBL3544659 0.061 0.014 CHEMBL3544674 | CHEMBL3544658 | |
| 0.144 | 0.024 | 0.144 | Calcium antagonist | 0.073 0.07 CHEMBL2074678 0.073 0.07 CHEMBL3544659 0.105 0.044 CHEMBL3544674 | ||
| 0.143 | 0.026 | 0.143 | Nitric-oxide synthase inhibitor | 0.086 0.085 CHEMBL3544658 | ||
| 0.16 | 0.046 | 0.195 | Sphingosine 1-phosphate receptor 5 antagonist | 0.195 0.014 CHEMBL3544658 0.164 0.041 CHEMBL2074678 0.164 0.041 CHEMBL3544659 0.178 0.025 CHEMBL3544674 | CHEMBL3544658 | |
| 0.159 | 0.045 | 0.163 | Topoisomerase II inhibitor | 0.163 0.044 CHEMBL3526716 | CHEMBL3526716 | |
| 0.137 | 0.024 | 0.174 | Acetylcholine nicotinic antagonist | 0.133 0.026 CHEMBL3544658 0.107 0.035 CHEMBL2074678 0.107 0.035 CHEMBL3544659 0.174 0.016 CHEMBL3544674 | CHEMBL3544674 | |
| 0.211 | 0.099 | 0.542 | Tumour necrosis factor alpha release inhibitor | 0.281 0.061 CHEMBL3544658 0.344 0.039 CHEMBL2074678 0.344 0.039 CHEMBL3544659 0.246 0.077 CHEMBL3544674 0.23 0.085 CHEMBL3526778 0.542 0.011 CHEMBL3526716 | CHEMBL3526716 | |
| 0.126 | 0.016 | 0.164 | Neuronal nicotinic receptor antagonist | 0.123 0.017 CHEMBL3544658 0.099 0.025 CHEMBL2074678 0.099 0.025 CHEMBL3544659 0.164 0.011 CHEMBL3544674 | CHEMBL3544674 | |
| 0.13 | 0.02 | 0.13 | Dopamine D4 antagonist | 0.065 0.039 CHEMBL3544658 0.068 0.037 CHEMBL2074678 0.068 0.037 CHEMBL3544659 | ||
| 0.146 | 0.038 | 0.146 | MAO B inhibitor | 0.086 0.069 CHEMBL3544658 | ||
| 0.143 | 0.041 | 0.143 | Papain-like protease (SARS coronavirus) inhibitor | |||
| 0.109 | 0.011 | 0.109 | Nicotinic neuronal receptor agonist | 0.08 0.021 CHEMBL3544658 0.054 0.041 CHEMBL2074678 0.054 0.041 CHEMBL3544659 0.103 0.012 CHEMBL3544674 | ||
| 0.177 | 0.082 | 0.197 | P-glycoprotein inhibitor | 0.16 0.102 CHEMBL3544658 0.196 0.067 CHEMBL2074678 0.196 0.067 CHEMBL3544659 0.197 0.066 CHEMBL3526716 | CHEMBL3526716 | |
| 0.108 | 0.02 | 0.108 | Nav1.7 sodium channel blocker | 0.082 0.032 CHEMBL3544658 0.07 0.044 CHEMBL2074678 0.07 0.044 CHEMBL3544659 0.083 0.031 CHEMBL3544674 | ||
| 0.116 | 0.029 | 0.117 | Phosphodiesterase 6D inhibitor | 0.091 0.072 CHEMBL3544658 0.105 0.043 CHEMBL3544674 0.117 0.027 CHEMBL3526716 | CHEMBL3526716 | |
| 0.095 | 0.009 | 0.108 | Nicotinic alpha3beta2 receptor antagonist | 0.084 0.012 CHEMBL3544658 0.058 0.029 CHEMBL2074678 0.058 0.029 CHEMBL3544659 0.108 0.006 CHEMBL3544674 | CHEMBL3544674 | |
| 0.26 | 0.174 | 0.491 | Analgesic | 0.385 0.091 CHEMBL3544658 0.275 0.161 CHEMBL2074678 0.275 0.161 CHEMBL3544659 0.491 0.052 CHEMBL3544674 | CHEMBL3544674 | |
| 0.172 | 0.087 | 0.336 | Hepatoprotectant | 0.134 0.128 CHEMBL2074678 0.134 0.128 CHEMBL3544659 0.148 0.112 CHEMBL3526778 0.336 0.021 CHEMBL3526716 | CHEMBL3526716 | |
| 0.095 | 0.01 | 0.12 | Nicotinic receptor alpha3 subunit antagonist | 0.096 0.01 CHEMBL3544658 0.063 0.018 CHEMBL2074678 0.063 0.018 CHEMBL3544659 0.12 0.008 CHEMBL3544674 | CHEMBL3544674 | |
| 0.096 | 0.014 | 0.096 | I kappa B kinase 2 inhibitor | 0.069 0.034 CHEMBL3544658 0.06 0.047 CHEMBL3544674 | ||
| 0.13 | 0.05 | 0.144 | Topoisomerase I inhibitor | 0.144 0.044 CHEMBL3526716 | CHEMBL3526716 | |
| 0.128 | 0.048 | 0.128 | Calcium channel (voltage-sensitive) blocker | 0.094 0.093 CHEMBL3544658 0.108 0.073 CHEMBL3544674 | ||
| 0.102 | 0.024 | 0.145 | Dopamine D1 antagonist | 0.129 0.018 CHEMBL3544658 0.145 0.016 CHEMBL2074678 0.145 0.016 CHEMBL3544659 0.083 0.031 CHEMBL3544674 | CHEMBL3544659 | |
| 0.182 | 0.105 | 0.264 | Potassium channel blocker | 0.151 0.134 CHEMBL3544658 0.264 0.06 CHEMBL3544674 | CHEMBL3544674 | |
| 0.139 | 0.063 | 0.139 | Acetylcholinesterase inhibitor | 0.107 0.093 CHEMBL2074678 0.107 0.093 CHEMBL3544659 | ||
| 0.172 | 0.098 | 0.228 | I kappa B kinase epsilon inhibitor | 0.204 0.067 CHEMBL3544658 0.228 0.05 CHEMBL2074678 0.228 0.05 CHEMBL3544659 0.156 0.113 CHEMBL3544674 | CHEMBL3544659 | |
| 0.119 | 0.046 | 0.119 | DOPA decarboxylase inhibitor | 0.113 0.054 CHEMBL3544658 0.093 0.092 CHEMBL3544674 | ||
| 0.11 | 0.039 | 0.13 | Acetylcholine M3 receptor agonist | 0.085 0.056 CHEMBL3544658 0.13 0.03 CHEMBL3544674 | CHEMBL3544674 | |
| 0.105 | 0.035 | 0.105 | I kappa B kinase inhibitor | 0.083 0.057 CHEMBL3544658 | ||
| 0.115 | 0.047 | 0.115 | Antiadrenergic | 0.096 0.059 CHEMBL3544658 0.111 0.05 CHEMBL2074678 0.111 0.05 CHEMBL3544659 0.099 0.056 CHEMBL3544674 | ||
| 0.113 | 0.047 | 0.113 | Adrenaline antagonist | 0.093 0.058 CHEMBL3544658 0.108 0.049 CHEMBL2074678 0.108 0.049 CHEMBL3544659 0.096 0.056 CHEMBL3544674 | ||
| 0.079 | 0.013 | 0.088 | Nicotinic receptor alpha4 subunit antagonist | 0.08 0.013 CHEMBL3544658 0.065 0.019 CHEMBL2074678 0.065 0.019 CHEMBL3544659 0.088 0.01 CHEMBL3544674 | CHEMBL3544674 | |
| 0.086 | 0.026 | 0.086 | Acetylcholine M2 receptor antagonist | 0.074 0.034 CHEMBL3544674 | ||
| 0.216 | 0.158 | 0.324 | Vasodilator, peripheral | 0.277 0.109 CHEMBL3544658 0.314 0.09 CHEMBL2074678 0.314 0.09 CHEMBL3544659 0.262 0.119 CHEMBL3544674 0.324 0.085 CHEMBL3526716 | CHEMBL3526716 | |
| 0.078 | 0.025 | 0.078 | 5 Hydroxytryptamine 5A antagonist | 0.059 0.047 CHEMBL3544658 0.056 0.052 CHEMBL2074678 0.056 0.052 CHEMBL3544659 | ||
| 0.07 | 0.019 | 0.087 | Acetylcholine M2 receptor agonist | 0.069 0.02 CHEMBL3544658 0.063 0.026 CHEMBL2074678 0.063 0.026 CHEMBL3544659 0.087 0.01 CHEMBL3544674 | CHEMBL3544674 | |
| 0.078 | 0.028 | 0.082 | 5 Hydroxytryptamine 3 agonist | 0.082 0.025 CHEMBL3544674 | CHEMBL3544674 | |
| 0.106 | 0.06 | 0.106 | MAO A inhibitor | 0.089 0.072 CHEMBL3544658 0.086 0.075 CHEMBL2074678 0.086 0.075 CHEMBL3544659 | ||
| 0.05 | 0.005 | 0.07 | Nicotinic alpha4beta2 receptor agonist | 0.05 0.005 CHEMBL3544658 0.039 0.008 CHEMBL2074678 0.039 0.008 CHEMBL3544659 0.07 0.003 CHEMBL3544674 | CHEMBL3544674 | |
| 0.08 | 0.035 | 0.08 | Acetylcholine M5 receptor agonist | |||
| 0.098 | 0.053 | 0.112 | Toll-Like receptor 3 antagonist | 0.103 0.046 CHEMBL3544658 0.112 0.036 CHEMBL2074678 0.112 0.036 CHEMBL3544659 0.086 0.079 CHEMBL3526778 | CHEMBL3544659 | |
| 0.074 | 0.029 | 0.074 | Protease activated receptor antagonist | |||
| 0.113 | 0.068 | 0.113 | Sphingosine 1-phosphate receptor 2 agonist | |||
| 0.14 | 0.097 | 0.23 | Melanin inhibitor | 0.153 0.077 CHEMBL3544658 0.165 0.064 CHEMBL2074678 0.165 0.064 CHEMBL3544659 0.127 0.121 CHEMBL3544674 0.23 0.032 CHEMBL3526716 | CHEMBL3526716 | |
| 0.136 | 0.094 | 0.139 | MAP kinase kinase 4 inhibitor | 0.127 0.123 CHEMBL3544658 0.139 0.088 CHEMBL3544674 | CHEMBL3544674 | |
| 0.11 | 0.068 | 0.156 | Nav1.5 sodium channel blocker | 0.156 0.024 CHEMBL3544658 0.134 0.039 CHEMBL2074678 0.134 0.039 CHEMBL3544659 0.135 0.038 CHEMBL3544674 0.126 0.047 CHEMBL3526778 | CHEMBL3544658 | |
| 0.065 | 0.027 | 0.065 | Nicotinic alpha7 receptor agonist | 0.051 0.041 CHEMBL3544674 | ||
| 0.074 | 0.035 | 0.074 | Dopamine D3 antagonist | |||
| 0.067 | 0.029 | 0.067 | 5 Hydroxytryptamine 5 antagonist | |||
| 0.075 | 0.04 | 0.113 | Dopamine agonist | 0.113 0.022 CHEMBL3544658 0.098 0.028 CHEMBL2074678 0.098 0.028 CHEMBL3544659 0.07 0.044 CHEMBL3544674 0.08 0.037 CHEMBL3526778 | CHEMBL3544658 | |
| 0.08 | 0.046 | 0.087 | Alpha 1b adrenoreceptor antagonist | 0.087 0.041 CHEMBL2074678 0.087 0.041 CHEMBL3544659 | CHEMBL3544659 | |
| 0.06 | 0.028 | 0.167 | Lysine-specific demethylase 1A inhibitor | 0.167 0.004 CHEMBL3544658 0.123 0.005 CHEMBL2074678 0.123 0.005 CHEMBL3544659 0.095 0.008 CHEMBL3544674 | CHEMBL3544658 | |
| 0.051 | 0.019 | 0.054 | GABA B receptor antagonist | 0.044 0.028 CHEMBL3544658 0.054 0.016 CHEMBL3544674 | CHEMBL3544674 | |
| 0.071 | 0.04 | 0.071 | Glutamate (mGluR7) antagonist | |||
| 0.088 | 0.057 | 0.088 | Antineoplastic alkaloid | |||
| 0.06 | 0.029 | 0.092 | Nicotinic receptor alpha7 subunit antagonist | 0.056 0.034 CHEMBL3544658 0.092 0.014 CHEMBL3544674 | CHEMBL3544674 | |
| 0.083 | 0.054 | 0.083 | Phosphodiesterase 11A inhibitor | |||
| 0.083 | 0.054 | 0.083 | Phosphodiesterase XI inhibitor | |||
| 0.108 | 0.08 | 0.126 | Interleukin 8 antagonist | 0.126 0.054 CHEMBL3544658 0.104 0.088 CHEMBL2074678 0.104 0.088 CHEMBL3544659 0.114 0.07 CHEMBL3544674 | CHEMBL3544658 | |
| 0.072 | 0.045 | 0.089 | Toll-Like receptor 7 antagonist | 0.065 0.051 CHEMBL3544658 0.069 0.047 CHEMBL2074678 0.069 0.047 CHEMBL3544659 0.089 0.029 CHEMBL3544674 | CHEMBL3544674 | |
| 0.04 | 0.013 | 0.04 | Endothelin receptor antagonist | |||
| 0.045 | 0.02 | 0.068 | GABA uptake inhibitor | 0.043 0.023 CHEMBL3544658 0.068 0.008 CHEMBL3544674 | CHEMBL3544674 | |
| 0.179 | 0.154 | 0.348 | DNA synthesis inhibitor | 0.183 0.148 CHEMBL3544658 0.348 0.031 CHEMBL3544674 0.294 0.046 CHEMBL3526716 | CHEMBL3544674 | |
| 0.033 | 0.008 | 0.033 | Endothelin B receptor antagonist | |||
| 0.139 | 0.114 | 0.237 | Tumour necrosis factor antagonist | 0.156 0.093 CHEMBL3544658 0.237 0.035 CHEMBL2074678 0.237 0.035 CHEMBL3544659 | CHEMBL3544659 | |
| 0.031 | 0.006 | 0.031 | Imidazoline I1 receptor antagonist | |||
| 0.083 | 0.059 | 0.127 | 5 Hydroxytryptamine 2C antagonist | 0.09 0.052 CHEMBL3544658 0.106 0.042 CHEMBL2074678 0.106 0.042 CHEMBL3544659 0.127 0.033 CHEMBL3544674 | CHEMBL3544674 | |
| 0.126 | 0.104 | 0.296 | NOS3 expression enhancer | 0.246 0.027 CHEMBL3544658 0.203 0.04 CHEMBL2074678 0.203 0.04 CHEMBL3544659 0.196 0.043 CHEMBL3544674 0.296 0.018 CHEMBL3526716 | CHEMBL3526716 | |
| 0.067 | 0.052 | 0.142 | 5 Hydroxytryptamine 1F antagonist | 0.077 0.045 CHEMBL3544658 0.062 0.057 CHEMBL2074678 0.062 0.057 CHEMBL3544659 0.142 0.018 CHEMBL3544674 | CHEMBL3544674 | |
| 0.07 | 0.057 | 0.094 | MAP-kinase-activated kinase 2 inhibitor | 0.071 0.056 CHEMBL3544658 0.094 0.032 CHEMBL3544674 | CHEMBL3544674 | |
| 0.055 | 0.044 | 0.055 | Alpha 1d adrenoreceptor antagonist | |||
| 0.023 | 0.013 | 0.023 | Endothelin A receptor antagonist | |||
| 0.044 | 0.034 | 0.087 | Mannosidase inhibitor | 0.087 0.007 CHEMBL3544674 0.073 0.01 CHEMBL3526716 | CHEMBL3544674 | |
| 0.076 | 0.068 | 0.102 | MAP-kinase-activated kinase inhibitor | 0.079 0.063 CHEMBL3544658 0.102 0.037 CHEMBL3544674 | CHEMBL3544674 | |
| 0.065 | 0.057 | 0.065 | Phosphodiesterase V inhibitor | |||
| 0.147 | 0.139 | 0.147 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | |||
| 0.017 | 0.01 | 0.031 | Nicotinic alpha4 receptor agonist | 0.023 0.005 CHEMBL3544658 0.017 0.011 CHEMBL2074678 0.017 0.011 CHEMBL3544659 0.031 0.004 CHEMBL3544674 | CHEMBL3544674 | |
| 0.123 | 0.117 | 0.136 | Neuropeptide Y1 antagonist | 0.136 0.088 CHEMBL3544658 0.132 0.097 CHEMBL2074678 0.132 0.097 CHEMBL3544659 0.133 0.093 CHEMBL3544674 | CHEMBL3544658 | |
| 0.235 | 0.23 | 0.684 | Cyclophilin D inhibitor | 0.411 0.085 CHEMBL3544658 0.333 0.135 CHEMBL2074678 0.333 0.135 CHEMBL3544659 0.392 0.095 CHEMBL3544674 0.349 0.123 CHEMBL3526778 0.684 0.016 CHEMBL3526716 | CHEMBL3526716 | |
| 0.039 | 0.033 | 0.055 | Dopamine D5 antagonist | 0.055 0.022 CHEMBL3544658 0.052 0.024 CHEMBL2074678 0.052 0.024 CHEMBL3544659 0.043 0.03 CHEMBL3544674 | CHEMBL3544658 | |
| 0.014 | 0.009 | 0.014 | Integrin beta6 antagonist | |||
| 0.011 | 0.007 | 0.011 | Imidazoline I2 receptor antagonist | |||
| 0.076 | 0.072 | 0.106 | GABA A receptor agonist | 0.106 0.033 CHEMBL3544674 | CHEMBL3544674 | |
| 0.032 | 0.032 | 0.055 | Ceramide glucosyltransferase inhibitor | 0.034 0.027 CHEMBL3544658 0.055 0.005 CHEMBL3544674 | CHEMBL3544674 | |
| 0.046 | 0.047 | 0.047 | Alpha tubulin antagonist | 0.047 0.045 CHEMBL2074678 0.047 0.045 CHEMBL3544659 | CHEMBL3544659 | |
| 0.151 | 0.156 | 0.289 | Vasodilator | 0.164 0.138 CHEMBL2074678 0.164 0.138 CHEMBL3544659 0.289 0.052 CHEMBL3526716 | CHEMBL3526716 | |
| 0.069 | 0.074 | 0.078 | GABA B receptor agonist | 0.078 0.046 CHEMBL3544658 0.078 0.046 CHEMBL2074678 0.078 0.046 CHEMBL3544659 0.07 0.069 CHEMBL3544674 | CHEMBL3544659 | |
| 0.025 | 0.031 | 0.034 | Purinergic P2Y14 antagonist | 0.034 0.016 CHEMBL3544674 | CHEMBL3544674 | |
| 0.044 | 0.051 | 0.049 | Sodium/calcium exchanger inhibitor | 0.049 0.037 CHEMBL3544658 | CHEMBL3544658 | |
| 0.088 | 0.094 | 0.149 | GABA receptor agonist | 0.102 0.075 CHEMBL3544658 0.149 0.037 CHEMBL3544674 | CHEMBL3544674 | |
| 0.034 | 0.042 | 0.073 | Neurokinin 1 antagonist | 0.073 0.011 CHEMBL3544674 | CHEMBL3544674 | |
| 0.077 | 0.086 | 0.086 | Check point kinase 2 inhibitor | 0.086 0.078 CHEMBL3544658 | CHEMBL3544658 | |
| 0.043 | 0.054 | 0.118 | Acetylcholine muscarinic agonist | 0.118 0.014 CHEMBL3544674 | CHEMBL3544674 | |
| 0.066 | 0.078 | 0.173 | Phosphodiesterase IV inhibitor | 0.173 0.017 CHEMBL2074678 0.173 0.017 CHEMBL3544659 | CHEMBL3544659 | |
| 0.034 | 0.048 | 0.057 | Phenylethanolamine N methyltransferase inhibitor | 0.043 0.022 CHEMBL3544658 0.038 0.034 CHEMBL2074678 0.038 0.034 CHEMBL3544659 0.057 0.009 CHEMBL3544674 | CHEMBL3544674 | |
| 0.12 | 0.135 | 0.33 | Nitric oxide antagonist | 0.149 0.096 CHEMBL3544658 0.165 0.084 CHEMBL2074678 0.165 0.084 CHEMBL3544659 0.33 0.035 CHEMBL3526716 | CHEMBL3526716 | |
| 0.024 | 0.039 | 0.033 | Melatonin agonist | 0.033 0.022 CHEMBL2074678 0.033 0.022 CHEMBL3544659 | CHEMBL3544659 | |
| 0.037 | 0.052 | 0.04 | Alpha 1L adrenoreceptor agonist | 0.04 0.038 CHEMBL3544674 | CHEMBL3544674 | |
| 0.099 | 0.115 | 0.135 | NADPH oxidase inhibitor | 0.11 0.097 CHEMBL3544658 0.135 0.066 CHEMBL2074678 0.135 0.066 CHEMBL3544659 0.111 0.094 CHEMBL3526716 | CHEMBL3544659 | |
| 0.03 | 0.047 | 0.083 | Dopamine D5 agonist | 0.083 0.005 CHEMBL3544658 0.053 0.015 CHEMBL2074678 0.053 0.015 CHEMBL3544659 0.062 0.011 CHEMBL3544674 | CHEMBL3544658 | |
| 0.021 | 0.039 | 0.045 | Nicotinic alpha3beta4 receptor agonist | 0.037 0.013 CHEMBL3544658 0.028 0.024 CHEMBL2074678 0.028 0.024 CHEMBL3544659 0.045 0.007 CHEMBL3544674 | CHEMBL3544674 | |
| 0.025 | 0.043 | 0.03 | Melatonin 1 agonist | 0.03 0.028 CHEMBL2074678 0.03 0.028 CHEMBL3544659 | CHEMBL3544659 | |
| 0.058 | 0.077 | 0.091 | Topoisomerase II alpha inhibitor | 0.091 0.045 CHEMBL3526716 | CHEMBL3526716 | |
| 0.043 | 0.062 | 0.077 | Alpha-mannosidase inhibitor | 0.077 0.012 CHEMBL3544674 0.063 0.024 CHEMBL3526716 | CHEMBL3544674 | |
| 0.027 | 0.048 | 0.034 | ADAM10 endopeptidase inhibitor | 0.034 0.023 CHEMBL3544674 | CHEMBL3544674 | |
| 0.049 | 0.07 | 0.057 | 5 Hydroxytryptamine 1B antagonist | 0.057 0.055 CHEMBL3544674 | CHEMBL3544674 | |
| 0.036 | 0.06 | 0.053 | CC chemokine 5 receptor antagonist | 0.053 0.033 CHEMBL3544674 | CHEMBL3544674 | |
| 0.019 | 0.046 | 0.072 | Sodium/glucose cotransporter inhibitor | 0.029 0.012 CHEMBL3544674 0.072 0.004 CHEMBL3526716 | CHEMBL3526716 | |
| 0.018 | 0.046 | 0.045 | Renin inhibitor | 0.045 0.02 CHEMBL3544674 | CHEMBL3544674 | |
| 0.026 | 0.055 | 0.046 | Vascular adhesion protein 1 inhibitor | 0.046 0.019 CHEMBL3544674 | CHEMBL3544674 | |
| 0.035 | 0.065 | 0.076 | Neurokinin antagonist | 0.076 0.018 CHEMBL3544674 | CHEMBL3544674 | |
| 0.026 | 0.056 | 0.052 | Somatostatin 4 agonist | 0.035 0.029 CHEMBL3544658 0.052 0.014 CHEMBL3544674 | CHEMBL3544674 | |
| 0.027 | 0.058 | 0.122 | Acetylcholine M1 receptor agonist | 0.122 0.01 CHEMBL3544674 | CHEMBL3544674 | |
| 0.026 | 0.058 | 0.048 | Substance P antagonist | 0.048 0.018 CHEMBL3544674 | CHEMBL3544674 | |
| 0.023 | 0.056 | 0.043 | Nicotinic receptor beta4 subunit antagonist | 0.033 0.032 CHEMBL3544658 0.043 0.02 CHEMBL3544674 | CHEMBL3544674 | |
| 0.027 | 0.062 | 0.05 | Glycine transporter inhibitor | 0.05 0.031 CHEMBL3544674 | CHEMBL3544674 | |
| 0.063 | 0.099 | 0.082 | Viral attachment inhibitor | 0.082 0.045 CHEMBL3544674 | CHEMBL3544674 | |
| 0.183 | 0.222 | 0.251 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.205 0.151 CHEMBL3544658 0.251 0.065 CHEMBL3544674 | CHEMBL3544674 | |
| 0.087 | 0.13 | 0.236 | Toll-Like receptor 2 antagonist | 0.216 0.017 CHEMBL3544658 0.236 0.012 CHEMBL2074678 0.236 0.012 CHEMBL3544659 0.175 0.036 CHEMBL3544674 | CHEMBL3544659 | |
| 0.023 | 0.066 | 0.065 | Dopamine D2 agonist | 0.065 0.019 CHEMBL3526778 | CHEMBL3526778 | |
| 0.077 | 0.126 | 0.098 | Glutamate (mGluR7) agonist | 0.098 0.063 CHEMBL2074678 0.098 0.063 CHEMBL3544659 | CHEMBL3544659 | |
| 0.051 | 0.101 | 0.13 | Phospholipase D inhibitor | 0.08 0.034 CHEMBL3544658 0.13 0.005 CHEMBL3544674 0.073 0.048 CHEMBL3526778 | CHEMBL3544674 | |
| 0.069 | 0.119 | 0.115 | Lanosterol 14 alpha demethylase inhibitor | 0.111 0.04 CHEMBL3544658 0.115 0.036 CHEMBL3544674 | CHEMBL3544674 | |
| 0.018 | 0.068 | 0.026 | Myristoyl transferase inhibitor | 0.026 0.021 CHEMBL3544674 | CHEMBL3544674 | |
| 0.131 | 0.184 | 0.203 | Spasmolytic | 0.203 0.117 CHEMBL3526716 | CHEMBL3526716 | |
| 0.033 | 0.088 | 0.049 | Histamine H4 receptor antagonist | 0.049 0.034 CHEMBL3544674 | CHEMBL3544674 | |
| 0.012 | 0.068 | 0.026 | Dopamine D1 agonist | 0.025 0.013 CHEMBL3544658 0.022 0.017 CHEMBL2074678 0.022 0.017 CHEMBL3544659 0.026 0.012 CHEMBL3526778 | CHEMBL3526778 | |
| 0.016 | 0.076 | 0.025 | Acid ceramidase inhibitor | 0.025 0.02 CHEMBL3544674 | CHEMBL3544674 | |
| 0.115 | 0.177 | 0.205 | Lipocortins synthesis antagonist | 0.164 0.087 CHEMBL3544658 0.145 0.113 CHEMBL2074678 0.145 0.113 CHEMBL3544659 0.205 0.053 CHEMBL3544674 0.145 0.113 CHEMBL3526716 | CHEMBL3544674 | |
| 0.104 | 0.168 | 0.144 | Adenylate cyclase stimulant | 0.133 0.095 CHEMBL3544658 0.144 0.073 CHEMBL3544674 | CHEMBL3544674 | |
| 0.063 | 0.127 | 0.101 | ATPase (Vacuolar H+) inhibitor | 0.101 0.038 CHEMBL3526716 | CHEMBL3526716 | |
| 0.053 | 0.119 | 0.069 | Keratolytic | 0.069 0.067 CHEMBL2074678 0.069 0.067 CHEMBL3544659 | CHEMBL3544659 | |
| 0.149 | 0.216 | 0.23 | Nitric-oxide synthase stimulant | 0.23 0.049 CHEMBL3544658 0.23 0.049 CHEMBL2074678 0.23 0.049 CHEMBL3544659 0.224 0.055 CHEMBL3544674 0.224 0.055 CHEMBL3526716 | CHEMBL3544659 | |
| 0.044 | 0.112 | 0.067 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.067 0.065 CHEMBL3544658 | CHEMBL3544658 | |
| 0.015 | 0.084 | 0.028 | Glutamate (mGluR2) antagonist | 0.028 0.024 CHEMBL3544674 | CHEMBL3544674 | |
| 0.073 | 0.143 | 0.118 | Tubulin antagonist | 0.118 0.082 CHEMBL2074678 0.118 0.082 CHEMBL3544659 | CHEMBL3544659 | |
| 0.035 | 0.111 | 0.062 | Dipeptidyl peptidase inhibitor | 0.062 0.023 CHEMBL3544674 | CHEMBL3544674 | |
| 0.031 | 0.108 | 0.05 | Dipeptidyl peptidase IV inhibitor | 0.05 0.02 CHEMBL3544674 | CHEMBL3544674 | |
| 0.022 | 0.101 | 0.093 | NMDA receptor subunit 3B antagonist | 0.062 0.018 CHEMBL3544658 0.093 0.011 CHEMBL3544674 | CHEMBL3544674 | |
| 0.03 | 0.113 | 0.05 | Myc inhibitor | 0.05 0.045 CHEMBL3544674 | CHEMBL3544674 | |
| 0.061 | 0.144 | 0.11 | Transcription factor NF kappa B stimulant | 0.11 0.031 CHEMBL3526716 | CHEMBL3526716 | |
| 0.131 | 0.214 | 0.496 | Hypoglycemic | 0.169 0.149 CHEMBL3544658 0.161 0.16 CHEMBL2074678 0.161 0.16 CHEMBL3544659 0.496 0.015 CHEMBL3526716 | CHEMBL3526716 | |
| 0.018 | 0.101 | 0.05 | Glutamate (mGluR group II) antagonist | 0.05 0.016 CHEMBL3544674 | CHEMBL3544674 | |
| 0.097 | 0.182 | 0.402 | Hemostatic | 0.136 0.087 CHEMBL3544658 0.136 0.087 CHEMBL3544674 0.402 0.008 CHEMBL3526778 0.381 0.009 CHEMBL3526716 | CHEMBL3526778 | |
| 0.066 | 0.152 | 0.257 | AMP-activated protein kinase stimulant | 0.109 0.06 CHEMBL3544658 0.097 0.075 CHEMBL2074678 0.097 0.075 CHEMBL3544659 0.096 0.076 CHEMBL3544674 0.257 0.006 CHEMBL3526716 | CHEMBL3526716 | |
| 0.115 | 0.202 | 0.165 | Phospholipase C inhibitor | 0.148 0.109 CHEMBL3544658 0.165 0.08 CHEMBL3544674 | CHEMBL3544674 | |
| 0.005 | 0.092 | 0.016 | NMDA receptor phencyclidine site antagonist | 0.016 0.01 CHEMBL3544674 | CHEMBL3544674 | |
| 0.145 | 0.232 | 0.586 | Transcription factor NF kappa B inhibitor | 0.206 0.163 CHEMBL3544658 0.244 0.132 CHEMBL2074678 0.244 0.132 CHEMBL3544659 0.586 0.033 CHEMBL3526716 | CHEMBL3526716 | |
| 0.012 | 0.103 | 0.027 | Nicotinic acid receptor 2 antagonist | 0.027 0.018 CHEMBL3544674 | CHEMBL3544674 | |
| 0.036 | 0.129 | 0.078 | Beta adrenoreceptor antagonist | 0.076 0.03 CHEMBL3544658 0.078 0.029 CHEMBL2074678 0.078 0.029 CHEMBL3544659 | CHEMBL3544659 | |
| 0.092 | 0.187 | 0.129 | Sphingosine 1-phosphate receptor 2 antagonist | 0.129 0.076 CHEMBL3544658 | CHEMBL3544658 | |
| 0.027 | 0.123 | 0.06 | CC chemokine 2 receptor antagonist | 0.06 0.032 CHEMBL3544674 | CHEMBL3544674 | |
| 0.141 | 0.239 | 0.346 | Cholesterol antagonist | 0.21 0.156 CHEMBL3544658 0.241 0.132 CHEMBL3544674 0.243 0.13 CHEMBL3526778 0.346 0.066 CHEMBL3526716 | CHEMBL3526716 | |
| 0.06 | 0.158 | 0.101 | Estrogen receptor beta antagonist | 0.101 0.062 CHEMBL3544658 0.089 0.085 CHEMBL2074678 0.089 0.085 CHEMBL3544659 | CHEMBL3544658 | |
| 0.005 | 0.106 | 0.033 | Cyclin T1 inhibitor | 0.033 0.005 CHEMBL3544674 | CHEMBL3544674 | |
| 0.058 | 0.16 | 0.131 | 5 Hydroxytryptamine 3A agonist | 0.091 0.088 CHEMBL3544658 0.131 0.047 CHEMBL3544674 | CHEMBL3544674 | |
| 0.039 | 0.141 | 0.065 | Protein kinase B alpha inhibitor | 0.065 0.053 CHEMBL3544674 | CHEMBL3544674 | |
| 0.017 | 0.121 | 0.057 | Glutamate (mGluR3) antagonist | 0.057 0.009 CHEMBL3544674 | CHEMBL3544674 | |
| 0.058 | 0.163 | 0.1 | EphA2 antagonist | 0.1 0.075 CHEMBL2074678 0.1 0.075 CHEMBL3544659 | CHEMBL3544659 | |
| 0.072 | 0.178 | 0.113 | Estrogen antagonist | 0.113 0.068 CHEMBL3544658 0.103 0.092 CHEMBL2074678 0.103 0.092 CHEMBL3544659 | CHEMBL3544658 | |
| 0.009 | 0.116 | 0.031 | Endothelial nitric-oxide synthase inhibitor | 0.031 0.021 CHEMBL3544674 | CHEMBL3544674 | |
| 0.135 | 0.246 | 0.188 | Hypoxia-inducible factor 1 alpha inhibitor | 0.188 0.167 CHEMBL2074678 0.188 0.167 CHEMBL3544659 | CHEMBL3544659 | |
| 0.031 | 0.143 | 0.107 | Glutamate receptor agonist | 0.107 0.033 CHEMBL3544674 | CHEMBL3544674 | |
| 0.077 | 0.19 | 0.243 | Protein kinase stimulant | 0.121 0.091 CHEMBL3544658 0.126 0.087 CHEMBL2074678 0.126 0.087 CHEMBL3544659 0.243 0.028 CHEMBL3526716 | CHEMBL3526716 | |
| 0.164 | 0.277 | 0.358 | Calcium channel activator | 0.315 0.077 CHEMBL3544658 0.356 0.046 CHEMBL2074678 0.356 0.046 CHEMBL3544659 0.358 0.045 CHEMBL3544674 0.23 0.171 CHEMBL3526778 | CHEMBL3544674 | |
| 0.008 | 0.124 | 0.036 | Sodium/glucose cotransporter 2 inhibitor | 0.036 0.009 CHEMBL3526716 | CHEMBL3526716 | |
| 0.058 | 0.178 | 0.149 | Vascular endothelial growth factor 3 antagonist | 0.114 0.102 CHEMBL3544658 0.149 0.067 CHEMBL2074678 0.149 0.067 CHEMBL3544659 | CHEMBL3544659 | |
| 0.032 | 0.152 | 0.101 | Na+ K+ transporting ATPase inhibitor | 0.101 0.031 CHEMBL3544674 0.088 0.043 CHEMBL3526716 | CHEMBL3544674 | |
| 0.099 | 0.222 | 0.266 | Platelet antagonist | 0.179 0.118 CHEMBL3544674 0.266 0.066 CHEMBL3526716 | CHEMBL3526716 | |
| 0.039 | 0.163 | 0.068 | Secretase beta inhibitor | 0.068 0.053 CHEMBL3544674 | CHEMBL3544674 | |
| 0.049 | 0.176 | 0.076 | Estrogen receptor alpha antagonist | 0.076 0.055 CHEMBL3544658 | CHEMBL3544658 | |
| 0.059 | 0.186 | 0.115 | Nav1.6 sodium channel blocker | 0.115 0.105 CHEMBL3544674 | CHEMBL3544674 | |
| 0.179 | 0.307 | 0.441 | Apoptosis agonist | 0.241 0.224 CHEMBL2074678 0.241 0.224 CHEMBL3544659 0.441 0.095 CHEMBL3526716 | CHEMBL3526716 | |
| 0.055 | 0.184 | 0.085 | Interleukin 5 antagonist | 0.08 0.072 CHEMBL3544658 0.085 0.063 CHEMBL3526716 | CHEMBL3526716 | |
| 0.065 | 0.196 | 0.189 | Cyclooxygenase 3 inhibitor | 0.189 0.023 CHEMBL3526716 | CHEMBL3526716 | |
| 0.025 | 0.159 | 0.083 | Sphingosine 1-phosphate receptor 3 antagonist | 0.061 0.036 CHEMBL3544658 0.083 0.015 CHEMBL3544674 | CHEMBL3544674 | |
| 0.055 | 0.189 | 0.109 | Adenylate cyclase inhibitor | 0.095 0.088 CHEMBL3544658 0.109 0.077 CHEMBL3544674 | CHEMBL3544674 | |
| 0.009 | 0.148 | 0.06 | Estrogen agonist | 0.06 0.03 CHEMBL3526778 | CHEMBL3526778 | |
| 0.084 | 0.223 | 0.186 | Insulin secretagoues | 0.186 0.044 CHEMBL3526716 | CHEMBL3526716 | |
| 0.055 | 0.195 | 0.283 | Beta glucuronidase inhibitor | 0.112 0.055 CHEMBL3544658 0.114 0.052 CHEMBL2074678 0.114 0.052 CHEMBL3544659 0.283 0.007 CHEMBL3526716 | CHEMBL3526716 | |
| 0.012 | 0.153 | 0.029 | Glutamate (mGluR1) agonist | 0.029 0.011 CHEMBL3544674 | CHEMBL3544674 | |
| 0.045 | 0.187 | 0.11 | Bronchodilator | 0.11 0.053 CHEMBL2074678 0.11 0.053 CHEMBL3544659 0.095 0.07 CHEMBL3526716 | CHEMBL3544659 | |
| 0.013 | 0.156 | 0.052 | Glutamate (mGluR group I) agonist | 0.052 0.029 CHEMBL3544674 | CHEMBL3544674 | |
| 0.026 | 0.172 | 0.086 | Heparanase inhibitor | 0.055 0.033 CHEMBL3526778 0.086 0.005 CHEMBL3526716 | CHEMBL3526716 | |
| 0.047 | 0.193 | 0.093 | Breast cancer-resistant protein inhibitor | 0.093 0.063 CHEMBL3526778 | CHEMBL3526778 | |
| 0.024 | 0.172 | 0.212 | NMDA 2B receptor antagonist | 0.051 0.042 CHEMBL3544658 0.212 0.005 CHEMBL3526778 | CHEMBL3526778 | |
| 0.007 | 0.155 | 0.021 | Glutamate (mGluR1a) agonist | 0.021 0.018 CHEMBL3544674 | CHEMBL3544674 | |
| 0.047 | 0.196 | 0.24 | GABA C receptor agonist | 0.099 0.067 CHEMBL3544658 0.24 0.015 CHEMBL3544674 | CHEMBL3544674 | |
| 0.028 | 0.178 | 0.089 | Sphingosine kinase inhibitor | 0.077 0.018 CHEMBL3544658 0.054 0.051 CHEMBL2074678 0.054 0.051 CHEMBL3544659 0.089 0.011 CHEMBL3544674 0.056 0.047 CHEMBL3526778 | CHEMBL3544674 | |
| 0.033 | 0.184 | 0.148 | NMDA receptor antagonist | 0.116 0.038 CHEMBL3544658 0.148 0.025 CHEMBL3544674 | CHEMBL3544674 | |
| 0.052 | 0.204 | 0.347 | Amylase inhibitor | 0.107 0.091 CHEMBL2074678 0.107 0.091 CHEMBL3544659 0.101 0.095 CHEMBL3544674 0.347 0.013 CHEMBL3526716 | CHEMBL3526716 | |
| 0.011 | 0.163 | 0.057 | NMDA receptor subunit 3A antagonist | 0.034 0.031 CHEMBL3544658 0.057 0.017 CHEMBL3544674 | CHEMBL3544674 | |
| 0.054 | 0.207 | 0.186 | Multidrug resistance-associated protein 1 inhibitor | 0.186 0.014 CHEMBL3526778 0.094 0.091 CHEMBL3526716 | CHEMBL3526778 | |
| 0.081 | 0.236 | 0.141 | Antimitotic | 0.141 0.131 CHEMBL3526778 | CHEMBL3526778 | |
| 0.141 | 0.296 | 0.372 | Apoptosis antagonist | 0.206 0.171 CHEMBL3544658 0.218 0.158 CHEMBL2074678 0.218 0.158 CHEMBL3544659 0.372 0.047 CHEMBL3526716 | CHEMBL3526716 | |
| 0.085 | 0.243 | 0.224 | Hypolipemic | 0.224 0.08 CHEMBL3526716 | CHEMBL3526716 | |
| 0.039 | 0.197 | 0.084 | Pim-3 kinase inhibitor | 0.084 0.069 CHEMBL3544674 | CHEMBL3544674 | |
| 0.123 | 0.286 | 0.182 | ErbB-1 antagonist | 0.182 0.112 CHEMBL2074678 0.182 0.112 CHEMBL3544659 | CHEMBL3544659 | |
| 0.004 | 0.172 | 0.045 | Arginase inhibitor | 0.045 0.018 CHEMBL3544674 | CHEMBL3544674 | |
| 0.025 | 0.195 | 0.09 | Glucose-6-phosphate translocase inhibitor | 0.049 0.041 CHEMBL3544658 0.058 0.026 CHEMBL2074678 0.058 0.026 CHEMBL3544659 0.09 0.008 CHEMBL3526716 | CHEMBL3526716 | |
| 0.023 | 0.193 | 0.096 | Phosphodiesterase 4B inhibitor | 0.096 0.027 CHEMBL2074678 0.096 0.027 CHEMBL3544659 | CHEMBL3544659 | |
| 0.048 | 0.222 | 0.091 | MAP kinase kinase 7 inhibitor | 0.091 0.023 CHEMBL3544674 | CHEMBL3544674 | |
| 0.017 | 0.191 | 0.062 | Sphingosine kinase 1 inhibitor | 0.049 0.018 CHEMBL3544658 0.062 0.009 CHEMBL3544674 | CHEMBL3544674 | |
| 0.081 | 0.257 | 0.138 | Interleukin 6 antagonist | 0.138 0.108 CHEMBL3526716 | CHEMBL3526716 | |
| 0.059 | 0.237 | 0.112 | Interleukin 1 antagonist | 0.112 0.102 CHEMBL2074678 0.112 0.102 CHEMBL3544659 | CHEMBL3544659 | |
| 0.084 | 0.263 | 0.369 | Non-steroidal antiinflammatory agent | 0.139 0.132 CHEMBL2074678 0.139 0.132 CHEMBL3544659 0.369 0.017 CHEMBL3526716 | CHEMBL3526716 | |
| 0.011 | 0.192 | 0.041 | Alpha 1d adrenoreceptor agonist | 0.041 0.025 CHEMBL3544674 | CHEMBL3544674 | |
| 0.014 | 0.195 | 0.048 | Phosphodiesterase 4A inhibitor | 0.048 0.037 CHEMBL2074678 0.048 0.037 CHEMBL3544659 | CHEMBL3544659 | |
| 0.033 | 0.218 | 0.101 | Glycine receptor antagonist | 0.101 0.032 CHEMBL3544674 0.074 0.067 CHEMBL3526778 0.082 0.054 CHEMBL3526716 | CHEMBL3544674 | |
| 0.076 | 0.266 | 0.111 | DNA repair enzyme inhibitor | 0.111 0.094 CHEMBL3526716 | CHEMBL3526716 | |
| 0.074 | 0.264 | 0.324 | Platelet adhesion inhibitor | 0.236 0.054 CHEMBL3526778 0.324 0.027 CHEMBL3526716 | CHEMBL3526716 | |
| 0.039 | 0.234 | 0.163 | HIV-1 integrase (Overall Integration) inhibitor | 0.163 0.021 CHEMBL3544658 0.108 0.048 CHEMBL2074678 0.108 0.048 CHEMBL3544659 0.13 0.034 CHEMBL3544674 | CHEMBL3544658 | |
| 0.037 | 0.236 | 0.075 | Glutamate (mGluR6) antagonist | 0.075 0.031 CHEMBL3544674 | CHEMBL3544674 | |
| 0.038 | 0.238 | 0.134 | Cholesterol synthesis inhibitor | 0.114 0.071 CHEMBL3544658 0.12 0.065 CHEMBL2074678 0.12 0.065 CHEMBL3544659 0.116 0.069 CHEMBL3544674 0.134 0.054 CHEMBL3526778 | CHEMBL3526778 | |
| 0.115 | 0.315 | 0.568 | Antithrombotic | 0.23 0.144 CHEMBL3544674 0.255 0.122 CHEMBL3526778 0.568 0.02 CHEMBL3526716 | CHEMBL3526716 | |
| 0.009 | 0.212 | 0.028 | Protein 30S ribosomal subunit inhibitor | 0.028 0.014 CHEMBL3526716 | CHEMBL3526716 | |
| 0.037 | 0.243 | 0.105 | Prolactin inhibitor | 0.104 0.052 CHEMBL3544658 0.105 0.051 CHEMBL3544674 | CHEMBL3544674 | |
| 0.045 | 0.255 | 0.206 | Lipid peroxidase inhibitor | 0.115 0.099 CHEMBL3544658 0.122 0.092 CHEMBL2074678 0.122 0.092 CHEMBL3544659 0.206 0.039 CHEMBL3526716 | CHEMBL3526716 | |
| 0.083 | 0.295 | 0.458 | Antioxidant | 0.194 0.119 CHEMBL3544658 0.221 0.101 CHEMBL2074678 0.221 0.101 CHEMBL3544659 0.238 0.09 CHEMBL3526778 0.458 0.025 CHEMBL3526716 | CHEMBL3526716 | |
| 0.01 | 0.223 | 0.03 | Protein kinase C beta II inhibitor | 0.03 0.029 CHEMBL3544674 | CHEMBL3544674 | |
| 0.087 | 0.3 | 0.149 | ATPase inhibitor | 0.149 0.102 CHEMBL3526716 | CHEMBL3526716 | |
| 0.052 | 0.269 | 0.105 | Electron transport complex I inhibitor | 0.105 0.071 CHEMBL2074678 0.105 0.071 CHEMBL3544659 | CHEMBL3544659 | |
| 0.019 | 0.238 | 0.077 | Androgen agonist | 0.077 0.025 CHEMBL3544674 | CHEMBL3544674 | |
| 0.026 | 0.246 | 0.089 | CDC25A inhibitor | 0.089 0.035 CHEMBL3526778 | CHEMBL3526778 | |
| 0.039 | 0.261 | 0.09 | Protein kinase C zeta inhibitor | 0.09 0.066 CHEMBL3526778 | CHEMBL3526778 | |
| 0.039 | 0.262 | 0.141 | GABA C receptor antagonist | 0.097 0.082 CHEMBL3544658 0.141 0.035 CHEMBL3544674 | CHEMBL3544674 | |
| 0.04 | 0.265 | 0.135 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.135 0.032 CHEMBL3544674 | CHEMBL3544674 | |
| 0.016 | 0.246 | 0.08 | Protein 50S ribosomal subunit inhibitor | 0.08 0.019 CHEMBL3526716 | CHEMBL3526716 | |
| 0.042 | 0.273 | 0.078 | MDM2 inhibitor | 0.078 0.023 CHEMBL3544674 | CHEMBL3544674 | |
| 0.02 | 0.253 | 0.07 | Sphingosine kinase 2 inhibitor | 0.07 0.022 CHEMBL3544658 0.062 0.029 CHEMBL3544674 | CHEMBL3544658 | |
| 0.01 | 0.245 | 0.063 | NMDA 2C receptor antagonist | 0.063 0.04 CHEMBL3544674 | CHEMBL3544674 | |
| 0.027 | 0.264 | 0.087 | Chemokine receptor antagonist | 0.087 0.078 CHEMBL3544674 | CHEMBL3544674 | |
| 0.05 | 0.289 | 0.144 | Toll-Like receptor antagonist | 0.128 0.074 CHEMBL3544658 0.144 0.06 CHEMBL2074678 0.144 0.06 CHEMBL3544659 0.118 0.087 CHEMBL3544674 | CHEMBL3544659 | |
| 0.013 | 0.253 | 0.031 | Glutamate (mGluR3) agonist | 0.031 0.027 CHEMBL3544674 | CHEMBL3544674 | |
| 0.105 | 0.345 | 0.222 | RNA-directed DNA polymerase inhibitor | 0.222 0.072 CHEMBL3544674 0.165 0.162 CHEMBL3526778 | CHEMBL3544674 | |
| 0.15 | 0.392 | 0.443 | Calcium channel L-type activator | 0.305 0.153 CHEMBL3544658 0.288 0.168 CHEMBL2074678 0.288 0.168 CHEMBL3544659 0.443 0.055 CHEMBL3544674 | CHEMBL3544674 | |
| 0.018 | 0.272 | 0.228 | Monophenol monooxygenase inhibitor | 0.088 0.085 CHEMBL3544658 0.098 0.077 CHEMBL2074678 0.098 0.077 CHEMBL3544659 0.228 0.027 CHEMBL3526716 | CHEMBL3526716 | |
| 0.052 | 0.308 | 0.091 | Glutamate release inhibitor | 0.091 0.059 CHEMBL3544674 | CHEMBL3544674 | |
| 0.014 | 0.28 | 0.031 | Toll-Like receptor 4 agonist | 0.031 0.01 CHEMBL3526778 0.031 0.01 CHEMBL3526716 | CHEMBL3526716 | |
| 0.012 | 0.281 | 0.04 | Dihydroorotase inhibitor | 0.04 0.038 CHEMBL3544674 | CHEMBL3544674 | |
| 0.023 | 0.292 | 0.057 | Pregnane X receptor antagonist | 0.057 0.04 CHEMBL3544674 | CHEMBL3544674 | |
| 0.036 | 0.31 | 0.101 | Bile acid receptor antagonist | 0.101 0.046 CHEMBL3544658 0.091 0.07 CHEMBL2074678 0.091 0.07 CHEMBL3544659 0.087 0.082 CHEMBL3526778 | CHEMBL3544658 | |
| 0.075 | 0.351 | 0.215 | Cyclic AMP phosphodiesterase inhibitor | 0.215 0.083 CHEMBL3526716 | CHEMBL3526716 | |
| 0.059 | 0.336 | 0.242 | Antiamyloidogenic | 0.19 0.106 CHEMBL2074678 0.19 0.106 CHEMBL3544659 0.242 0.075 CHEMBL3526716 | CHEMBL3526716 | |
| 0.069 | 0.347 | 0.24 | Interferon gamma antagonist | 0.135 0.101 CHEMBL3544658 0.129 0.113 CHEMBL2074678 0.129 0.113 CHEMBL3544659 0.145 0.085 CHEMBL3544674 0.24 0.03 CHEMBL3526716 | CHEMBL3526716 | |
| 0.006 | 0.288 | 0.073 | NMDA 2 receptor antagonist | 0.073 0.049 CHEMBL3544658 0.062 0.06 CHEMBL3526778 | CHEMBL3544658 | |
| 0.048 | 0.337 | 0.159 | MAP3K9 inhibitor | 0.159 0.048 CHEMBL3544674 | CHEMBL3544674 | |
| 0.043 | 0.332 | 0.147 | Amyloid beta aggregation inhibitor | 0.147 0.11 CHEMBL2074678 0.147 0.11 CHEMBL3544659 | CHEMBL3544659 | |
| 0.023 | 0.315 | 0.075 | Glucosylceramidase inhibitor | 0.075 0.018 CHEMBL3544674 | CHEMBL3544674 | |
| 0.049 | 0.343 | 0.146 | Farnesoid X receptor antagonist | 0.146 0.057 CHEMBL3544658 0.136 0.071 CHEMBL2074678 0.136 0.071 CHEMBL3544659 | CHEMBL3544658 | |
| 0.11 | 0.407 | 0.224 | Tyrosine 3 hydroxylase inhibitor | 0.224 0.098 CHEMBL3544658 0.189 0.157 CHEMBL2074678 0.189 0.157 CHEMBL3544659 0.223 0.1 CHEMBL3544674 | CHEMBL3544658 | |
| 0.032 | 0.33 | 0.057 | Lipocortins synthesis agonist | 0.057 0.042 CHEMBL3526716 | CHEMBL3526716 | |
| 0.097 | 0.397 | 0.315 | Toll-Like receptor 7 agonist | 0.202 0.198 CHEMBL2074678 0.202 0.198 CHEMBL3544659 0.315 0.101 CHEMBL3526716 | CHEMBL3526716 | |
| 0.009 | 0.31 | 0.099 | HIV-1 integrase (Strand Transfer) inhibitor | 0.099 0.023 CHEMBL3526778 | CHEMBL3526778 | |
| 0.027 | 0.331 | 0.078 | Sphingosine 1-phosphate receptor antagonist | 0.078 0.049 CHEMBL3544674 | CHEMBL3544674 | |
| 0.029 | 0.333 | 0.072 | Glycine receptor agonist | 0.072 0.051 CHEMBL3544674 | CHEMBL3544674 | |
| 0.044 | 0.349 | 0.131 | Cell wall synthesis inhibitor | 0.125 0.092 CHEMBL3526778 0.131 0.085 CHEMBL3526716 | CHEMBL3526716 | |
| 0.028 | 0.336 | 0.063 | Adenine nucleotide translocase inhibitor | 0.063 0.024 CHEMBL3526778 0.057 0.035 CHEMBL3526716 | CHEMBL3526778 | |
| 0.042 | 0.351 | 0.151 | Cell adhesion inhibitor | 0.151 0.046 CHEMBL3526716 | CHEMBL3526716 | |
| 0.005 | 0.316 | 0.037 | 1,3-Beta-glucan synthase inhibitor | 0.037 0.005 CHEMBL3526778 | CHEMBL3526778 | |
| 0.053 | 0.365 | 0.417 | Free radical scavenger | 0.183 0.111 CHEMBL3544658 0.213 0.088 CHEMBL2074678 0.213 0.088 CHEMBL3544659 0.417 0.026 CHEMBL3526716 | CHEMBL3526716 | |
| 0.093 | 0.407 | 0.329 | Toll-Like receptor agonist | 0.329 0.094 CHEMBL3526716 | CHEMBL3526716 | |
| 0.007 | 0.331 | 0.114 | Antineoplastic antibiotic | 0.114 0.041 CHEMBL3526716 | CHEMBL3526716 | |
| 0.062 | 0.387 | 0.138 | CF transmembrane conductance regulator agonist | 0.138 0.099 CHEMBL3544658 0.133 0.11 CHEMBL2074678 0.133 0.11 CHEMBL3544659 | CHEMBL3544658 | |
| 0.015 | 0.351 | 0.087 | Androgen antagonist | 0.087 0.057 CHEMBL3544674 | CHEMBL3544674 | |
| 0.035 | 0.374 | 0.067 | Prolactin release inhibitor | 0.067 0.029 CHEMBL3544674 | CHEMBL3544674 | |
| 0.009 | 0.349 | 0.094 | HIV-1 integrase (3'-Processing) inhibitor | 0.094 0.028 CHEMBL3526778 | CHEMBL3526778 | |
| 0.014 | 0.354 | 0.075 | Protein kinase C beta inhibitor | 0.075 0.039 CHEMBL3544674 | CHEMBL3544674 | |
| 0.036 | 0.377 | 0.148 | Toll-Like receptor 4 antagonist | 0.148 0.022 CHEMBL3526716 | CHEMBL3526716 | |
| 0.014 | 0.356 | 0.099 | Protein-tyrosine phosphatase 1B inhibitor | 0.099 0.079 CHEMBL3526778 | CHEMBL3526778 | |
| 0.029 | 0.372 | 0.229 | Thrombolytic | 0.229 0.039 CHEMBL3526716 | CHEMBL3526716 | |
| 0.003 | 0.349 | 0.024 | Estrone sulfatase inhibitor | 0.024 0.013 CHEMBL3526778 | CHEMBL3526778 | |
| 0.013 | 0.362 | 0.035 | Glutamate (mGluR8) agonist | 0.035 0.033 CHEMBL3544674 | CHEMBL3544674 | |
| 0.032 | 0.381 | 0.072 | Vanilloid 4 agonist | 0.072 0.057 CHEMBL3544674 | CHEMBL3544674 | |
| 0.017 | 0.371 | 0.222 | Expectorant | 0.222 0.016 CHEMBL3526716 | CHEMBL3526716 | |
| 0.09 | 0.445 | 0.133 | Ca2+-transporting ATPase inhibitor | 0.133 0.105 CHEMBL3544674 | CHEMBL3544674 | |
| 0.019 | 0.375 | 0.063 | HIV-1 integrase inhibitor | 0.063 0.061 CHEMBL3526778 | CHEMBL3526778 | |
| 0.033 | 0.4 | 0.102 | Nav1.4 sodium channel blocker | 0.097 0.081 CHEMBL3544674 0.102 0.073 CHEMBL3526778 | CHEMBL3526778 | |
| 0.029 | 0.405 | 0.086 | Xanthine oxidase inhibitor | 0.086 0.079 CHEMBL3526716 | CHEMBL3526716 | |
| 0.01 | 0.389 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.02 CHEMBL3544674 | CHEMBL3544674 | |
| 0.022 | 0.402 | 0.087 | Creatine kinase inhibitor | 0.087 0.076 CHEMBL3544658 | CHEMBL3544658 | |
| 0.071 | 0.476 | 0.576 | Antibacterial | 0.234 0.192 CHEMBL3526778 0.576 0.023 CHEMBL3526716 | CHEMBL3526716 | |
| 0.013 | 0.423 | 0.056 | Antibiotic Aminoglycoside-like | 0.056 0.01 CHEMBL3526716 | CHEMBL3526716 | |
| 0.135 | 0.545 | 0.317 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.317 0.19 CHEMBL3544674 | CHEMBL3544674 | |
| 0.105 | 0.517 | 0.66 | Antiinflammatory | 0.323 0.194 CHEMBL3544658 0.292 0.223 CHEMBL2074678 0.292 0.223 CHEMBL3544659 0.297 0.218 CHEMBL3544674 0.283 0.231 CHEMBL3526778 0.66 0.039 CHEMBL3526716 | CHEMBL3526716 | |
| 0.02 | 0.433 | 0.048 | Antiviral (Hepatitis D) | 0.048 0.04 CHEMBL3544674 | CHEMBL3544674 | |
| 0.042 | 0.456 | 0.28 | Interleukin agonist | 0.205 0.116 CHEMBL3544658 0.161 0.157 CHEMBL2074678 0.161 0.157 CHEMBL3544659 0.28 0.058 CHEMBL3544674 0.272 0.063 CHEMBL3526716 | CHEMBL3544674 | |
| 0.094 | 0.511 | 0.344 | Interleukin 2 agonist | 0.284 0.086 CHEMBL3544674 0.344 0.048 CHEMBL3526716 | CHEMBL3526716 | |
| 0.056 | 0.476 | 0.21 | Superoxide dismutase inhibitor | 0.167 0.16 CHEMBL3544658 0.198 0.12 CHEMBL2074678 0.198 0.12 CHEMBL3544659 0.21 0.106 CHEMBL3526778 | CHEMBL3526778 | |
| 0.021 | 0.444 | 0.179 | Protein-tyrosine phosphatase inhibitor | 0.179 0.057 CHEMBL3526778 | CHEMBL3526778 | |
| 0.026 | 0.45 | 0.082 | Triose-phosphate isomerase inhibitor | 0.082 0.073 CHEMBL3544674 | CHEMBL3544674 | |
| 0.024 | 0.457 | 0.155 | Alpha-N-acetylglucosaminidase inhibitor | 0.155 0.052 CHEMBL3544674 | CHEMBL3544674 | |
| 0.018 | 0.466 | 0.079 | Cell adhesion molecule inhibitor | 0.079 0.054 CHEMBL3526716 | CHEMBL3526716 | |
| 0.017 | 0.468 | 0.065 | Interferon inducer | 0.065 0.043 CHEMBL3544674 | CHEMBL3544674 | |
| 0.013 | 0.475 | 0.057 | Sphingosine 1-phosphate receptor 1 antagonist | 0.057 0.036 CHEMBL3544674 | CHEMBL3544674 | |
| 0.015 | 0.481 | 0.074 | Interferon agonist | 0.074 0.062 CHEMBL3544674 | CHEMBL3544674 | |
| 0.023 | 0.498 | 0.162 | Dual specificity phosphatase 3 inhibitor | 0.162 0.087 CHEMBL3526778 | CHEMBL3526778 | |
| 0.012 | 0.502 | 0.07 | Thrombin inhibitor | 0.07 0.055 CHEMBL3526778 | CHEMBL3526778 | |
| 0.028 | 0.522 | 0.217 | DNA methyltransferase I inhibitor | 0.217 0.061 CHEMBL3526716 | CHEMBL3526716 | |
| 0.003 | 0.531 | 0.206 | Cholecystokinin A agonist | 0.206 0.003 CHEMBL3526778 | CHEMBL3526778 | |
| 0.021 | 0.553 | 0.486 | Angiogenesis stimulant | 0.318 0.043 CHEMBL3526778 0.486 0.013 CHEMBL3526716 | CHEMBL3526716 | |
| 0.021 | 0.556 | 0.154 | Dual specificity phosphatase inhibitor | 0.154 0.09 CHEMBL3526778 | CHEMBL3526778 | |
| 0.027 | 0.562 | 0.234 | DNA methylase inhibitor | 0.234 0.057 CHEMBL3526716 | CHEMBL3526716 | |
| 0.017 | 0.575 | 0.316 | Anticoagulant | 0.316 0.026 CHEMBL3526778 0.149 0.082 CHEMBL3526716 | CHEMBL3526778 | |
| 0.019 | 0.579 | 0.092 | Thioredoxin inhibitor | 0.092 0.059 CHEMBL3526716 | CHEMBL3526716 | |
| 0.017 | 0.581 | 0.238 | Immunostimulant | 0.238 0.101 CHEMBL3526716 | CHEMBL3526716 | |
| 0.033 | 0.599 | 0.349 | Angiogenesis inhibitor | 0.349 0.071 CHEMBL3526778 | CHEMBL3526778 | |
| 0.003 | 0.58 | 0.241 | Cholecystokinin agonist | 0.241 0.003 CHEMBL3526778 | CHEMBL3526778 | |
| 0.009 | 0.591 | 0.393 | Cholecystokinin B agonist | 0.393 0.003 CHEMBL3526778 | CHEMBL3526778 | |
| 0.072 | 0.685 | 0.302 | Peptidyltransferase inhibitor | 0.302 0.024 CHEMBL3526716 | CHEMBL3526716 | |
| 0.031 | 0.647 | 0.097 | Interleukin 12 antagonist | 0.097 0.058 CHEMBL3526716 | CHEMBL3526716 | |
| 0.028 | 0.653 | 0.125 | Hexokinase inhibitor | 0.125 0.111 CHEMBL3526716 | CHEMBL3526716 | |
| 0.028 | 0.668 | 0.362 | Immunosuppressant | 0.362 0.08 CHEMBL3526716 | CHEMBL3526716 | |
| 0.003 | 0.656 | 0.071 | Cholecystokinin antagonist | 0.071 0.014 CHEMBL3526778 | CHEMBL3526778 | |
| 0.003 | 0.659 | 0.05 | Cholecystokinin B antagonist | 0.05 0.01 CHEMBL3526778 | CHEMBL3526778 | |
| 0.003 | 0.663 | 0.106 | Cholecystokinin A antagonist | 0.106 0.008 CHEMBL3526778 | CHEMBL3526778 | |
| 0.004 | 0.76 | 0.218 | Selectin antagonist | 0.059 0.05 CHEMBL3526778 0.218 0.01 CHEMBL3526716 | CHEMBL3526716 | |
| 0.018 | 0.821 | 0.227 | Immunomodulator | 0.227 0.135 CHEMBL3526716 | CHEMBL3526716 | |
| 0.048 | 0.916 | 0.122 | CC chemokine 6 receptor antagonist | 0.122 0.107 CHEMBL3526716 | CHEMBL3526716 | |
| 0.003 | 0.893 | 0.026 | NMDA 2D receptor antagonist | 0.026 0.021 CHEMBL3526778 | CHEMBL3526778 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |